Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation.

PubWeight™: 3.46‹?› | Rank: Top 1%

🔗 View Article (PMC 1171747)

Published in EMBO J on December 01, 1999

Authors

D V Bulavin1, S Saito, M C Hollander, K Sakaguchi, C W Anderson, E Appella, A J Fornace

Author Affiliations

1: Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Articles citing this

(truncated to the top 100)

A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol (2005) 5.68

Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell (2006) 5.40

Modulation of mammalian life span by the short isoform of p53. Genes Dev (2004) 4.52

Mechanism of p38 MAP kinase activation in vivo. Genes Dev (2003) 3.36

Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol (2010) 3.28

Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol (2000) 3.12

PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev (2005) 2.85

Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A. Proc Natl Acad Sci U S A (2005) 2.59

Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J (2001) 2.38

p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J (2000) 2.38

Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol (2009) 2.34

Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci (2008) 2.18

Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes. J Exp Med (2000) 2.07

The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev (2008) 2.06

c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev (2006) 1.84

p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci U S A (2010) 1.77

The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. Cancer Res (2008) 1.71

An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model. Genes Dev (2016) 1.70

Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol Cell Biol (2002) 1.67

P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell (2003) 1.65

Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry. Genes Dev (2013) 1.57

Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol Cell Biol (2001) 1.54

Role of p53 serine 46 in p53 target gene regulation. PLoS One (2011) 1.48

Negative feedback regulation of MKK6 mRNA stability by p38alpha mitogen-activated protein kinase. Mol Cell Biol (2003) 1.47

Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol (2005) 1.47

p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol Biol Cell (2005) 1.46

Another fork in the road--life or death decisions by the tumour suppressor p53. EMBO Rep (2013) 1.43

5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation. EMBO J (2004) 1.42

Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res (2009) 1.41

Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol Cell Biol (2003) 1.38

Identification of nucleolin and nucleophosmin as genotoxic stress-responsive RNA-binding proteins. Nucleic Acids Res (2002) 1.37

Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia (2000) 1.36

Pumilio 1 suppresses multiple activators of p53 to safeguard spermatogenesis. Curr Biol (2012) 1.34

Retracted High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest (2007) 1.34

Inhibition of centrosome protein assembly leads to p53-dependent exit from the cell cycle. J Cell Biol (2006) 1.34

The p38 MAPK stress pathway as a tumor suppressor or more? Front Biosci (2008) 1.31

Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint. EMBO J (2006) 1.28

Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res (2008) 1.25

CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J Exp Med (2003) 1.25

DNA damage and the balance between survival and death in cancer biology. Nat Rev Cancer (2015) 1.25

Regulation of the Wip1 phosphatase and its effects on the stress response. Front Biosci (Landmark Ed) (2012) 1.24

Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin. J Biol Chem (2011) 1.23

Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med (2005) 1.22

Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Mol Cell Biol (2002) 1.20

p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. J Biol Chem (2009) 1.19

Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression. Mol Cell Biol (2004) 1.16

Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol Biol Cell (2001) 1.16

SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition. Oncogene (2010) 1.14

The p57 CDKi integrates stress signals into cell-cycle progression to promote cell survival upon stress. EMBO J (2012) 1.12

A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. EMBO J (2007) 1.10

Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends Biochem Sci (2014) 1.10

Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis. Mol Cell Biol (2006) 1.09

The 14-3-3tau phosphoserine-binding protein is required for cardiomyocyte survival. Mol Cell Biol (2006) 1.08

Cancer risk at low doses of ionizing radiation: artificial neural networks inference from atomic bomb survivors. J Radiat Res (2013) 1.06

Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Biochemistry (2009) 1.05

The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma. J Biol Chem (2010) 1.04

Ionizing radiation-induced responses in human cells with differing TP53 status. Int J Mol Sci (2013) 1.04

Mechanical cell competition kills cells via induction of lethal p53 levels. Nat Commun (2016) 1.02

Aberrant expression of miR-638 contributes to benzo(a)pyrene-induced human cell transformation. Toxicol Sci (2011) 1.02

UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53. Biochem J (2002) 1.00

MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy. Autophagy (2012) 1.00

Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner. Mol Cell Biol (2012) 0.97

Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor. J Virol (2007) 0.97

Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β. Cardiovasc Res (2010) 0.97

Abnormal mitosis triggers p53-dependent cell cycle arrest in human tetraploid cells. Chromosoma (2013) 0.96

Posttranslational phosphorylation of mutant p53 protein in tumor development. Med Mol Morphol (2006) 0.96

p38 mitogen-activated protein kinase promotes cell survival in response to DNA damage but is not required for the G(2) DNA damage checkpoint in human cancer cells. Mol Cell Biol (2010) 0.95

Review of the anticancer activities of bee products. Asian Pac J Trop Biomed (2014) 0.95

15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53. J Biol Chem (2008) 0.95

Identification of HEXIM1 as a positive regulator of p53. J Biol Chem (2012) 0.94

Requirement of ATM for rapid p53 phosphorylation at Ser46 without Ser/Thr-Gln sequences. Mol Cell Biol (2010) 0.94

Oxidative stress in aging human skin. Biomolecules (2015) 0.94

Ultraviolet irradiation-induced K(+) channel activity involving p53 activation in corneal epithelial cells. Oncogene (2005) 0.93

Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells. J Endocrinol (2010) 0.90

Pathway connectivity and signaling coordination in the yeast stress-activated signaling network. Mol Syst Biol (2014) 0.90

JNK and p38 mitogen-activated protein kinase pathways contribute to porcine circovirus type 2 infection. J Virol (2009) 0.90

Salvianolic acid B induces apoptosis in human glioma U87 cells through p38-mediated ROS generation. Cell Mol Neurobiol (2013) 0.90

Helicobacter pylori bacteria alter the p53 stress response via ERK-HDM2 pathway. Oncotarget (2015) 0.89

p38γ regulates UV-induced checkpoint signaling and repair of UV-induced DNA damage. Protein Cell (2010) 0.89

PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells. Cell Death Dis (2011) 0.89

A conserved amphipathic helix in the N-terminal regulatory region of the papillomavirus E1 helicase is required for efficient viral DNA replication. J Virol (2011) 0.88

Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Res (2015) 0.88

Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells. Invest Ophthalmol Vis Sci (2007) 0.87

Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25C. EMBO J (2003) 0.87

Towards an understanding of the role of p53 in adrenocortical carcinogenesis. Mol Cell Endocrinol (2011) 0.86

Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition. Int J Oncol (2013) 0.86

LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1). PLoS One (2011) 0.86

MKK7 and ARF: new players in the DNA damage response scenery. Cell Cycle (2014) 0.86

Long-term Activation of c-Jun N-terminal Kinase through Receptor Interacting Protein is Associated with DNA Damage-induced Cell Death. Korean J Physiol Pharmacol (2008) 0.85

Procaspase 8 and Bax are up-regulated by distinct pathways in Streptococcal pyrogenic exotoxin B-induced apoptosis. J Biol Chem (2009) 0.85

HIV infection upregulates caveolin 1 expression to restrict virus production. J Virol (2010) 0.84

Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity. J Proteome Res (2007) 0.84

Apigenin induces DNA damage through the PKCδ-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA repair. Biochem Pharmacol (2012) 0.84

Chk2 mediates RITA-induced apoptosis. Cell Death Differ (2011) 0.84

The prolyl isomerase Pin1 is overexpressed in human esophageal cancer. Oncol Lett (2011) 0.84

PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation. J Ovarian Res (2013) 0.84

Phosphorylation of Tip60 by p38α regulates p53-mediated PUMA induction and apoptosis in response to DNA damage. Oncotarget (2014) 0.83

Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil. Cancer Biol Ther (2014) 0.83

Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NFkappaB activation: role of p38 MAP kinase. Carcinogenesis (2005) 0.82

Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytes. Mol Cell Biol (2011) 0.82

Articles by these authors

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell (1992) 19.87

Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61

Processing of adenovirus 2-induced proteins. J Virol (1973) 12.52

Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (1998) 11.90

An information-intensive approach to the molecular pharmacology of cancer. Science (1997) 11.43

Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (1998) 10.89

HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science (1992) 8.68

DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev (1998) 7.78

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med (1988) 7.12

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A (1994) 6.93

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93

Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A (1987) 6.90

The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science (1989) 6.89

Mouse beta 2-microglobulin cDNA clones: a screening procedure for cDNA clones corresponding to rare mRNAs. Proc Natl Acad Sci U S A (1981) 6.67

p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol (2000) 6.23

Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science (1994) 6.11

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science (1992) 5.99

DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev (1997) 5.76

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med (1994) 5.67

A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53

Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc Natl Acad Sci U S A (1982) 5.50

A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell (1988) 5.49

Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem (2001) 5.43

Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol (1989) 5.25

Repair of gamma-ray-induced DNA base damage in xeroderma pigmentosum cells. Radiat Res (1986) 5.08

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature (2000) 4.90

Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett (1989) 4.75

Rapid analysis of amino acid phenylthiohydantoins by high-performance liquid chromatography. Anal Biochem (1977) 4.64

DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell (1995) 4.64

Mapping of late adenovirus genes by cell-free translation of RNA selected by hybridization to specific DNA fragments. Proc Natl Acad Sci U S A (1975) 4.35

Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res (1997) 4.34

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol (1995) 4.31

DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci U S A (1988) 4.30

The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol (1994) 4.15

Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol (1998) 3.95

Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med (1989) 3.89

Identification of the SV40 agnogene product: a DNA binding protein. Nature (1981) 3.80

NMR structure of a specific DNA complex of Zn-containing DNA binding domain of GATA-1. Science (1993) 3.74

Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol (1992) 3.68

Identification of the initiation site of poliovirus polyprotein synthesis. J Virol (1982) 3.62

Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus. Proc Natl Acad Sci U S A (1983) 3.58

Location and identification of the genes for adenovirus type 2 early polypeptides. Cell (1976) 3.58

An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci U S A (1990) 3.53

Cell-free synthesis of adenovirus 2 proteins programmed by fractionated messenger RNA: a comparison of polypeptide products and messenger RNA lengths. Proc Natl Acad Sci U S A (1974) 3.52

A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature (1996) 3.50

Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science (1992) 3.39

Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J Virol (1984) 3.38

p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J (2001) 3.37

Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A (1985) 3.31

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol (1994) 3.30

Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol Cell Biol (1990) 3.30

Isolation and characterization of linear deoxyribonucleic acid plasmids from Kluyveromyces lactis and the plasmid-associated killer character. J Bacteriol (1981) 3.30

Membrane fractions active in poliovirus RNA replication contain VPg precursor polypeptides. Virology (1983) 3.28

Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J (1990) 3.27

Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature (2001) 3.25

Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J Cell Biol (1998) 3.23

H-2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J (1992) 3.21

Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci U S A (1990) 3.20

Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A (1997) 3.19

The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15

Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol Cell Biol (1992) 3.10

A membrane-associated precursor to poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide. Cell (1982) 3.07

Genomic instability in Gadd45a-deficient mice. Nat Genet (1999) 3.01

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med (1996) 2.99

High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science (1994) 2.98

DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy. Nucleic Acids Res (1987) 2.93

Poliovirus replication proteins: RNA sequence encoding P3-1b and the sites of proteolytic processing. Proc Natl Acad Sci U S A (1981) 2.91

GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci U S A (1999) 2.80

Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol (1997) 2.79

Further mapping of late adenovirus genes by cell-free translation of RNA selected by hybridization to specific DNA fragments. Cell (1977) 2.78

Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol (1993) 2.77

Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat Struct Biol (1995) 2.75

The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J Biol Chem (1987) 2.73

Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci U S A (1989) 2.73

Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J Virol (1999) 2.65

Balloon pump-induced pulsatile perfusion during cardiopulmonary bypass does not improve brain oxygenation. J Thorac Cardiovasc Surg (1999) 2.65

Identification of a gene encoding a yeast histone H4 acetyltransferase. J Biol Chem (1995) 2.62